Oxford University Innovation unveils support for impact-driven businesses from academic ideas.
We publish news of technology innovations, investment opportunities, together with updates from spin-out & start-up companies and licensees
The University of Oxford spinout also inks clinical paper in Lancet Psychiatry, appoints CEO and sets up Oxford HQ and London development hub.
Dr. Georg C. Terstappen has been appointed to the role of Chief Scientific Officer (CSO) of spinout OxStem Ltd.
Celleron Therapeutics, spun out of the University in 2005, has commenced a Phase Ib/II clinical trial investigating drug combination therapy for colorectal cancer.
Support-HF, developed by The George Institute for Global Health at the University of Oxford and Oxford University Hospitals NHS Foundation Trust, will support patients and clinicians in managing heart failure and curate data for medical research using Clinical AI.
Oxford University Innovation licenses sensors for garlic, ginger and turmeric to Zimmer and Peacock.
Opsydia, an Oxford University spinout founded last year to create a new level of diamond and gemstone security, officially launches with De Beers deal.